Status:
COMPLETED
Inflammation After Laparoscopic Robot-assisted Surgery for Locally Advanced Rectal Cancer
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
University of Oslo
Conditions:
Locally Advanced Rectal Cancer
Abdominoperineal Resection
Eligibility:
All Genders
18-100 years
Brief Summary
The intention of the study is to explore metabolic and inflammatory parameters in the pelvis and systemically after abdominoperineal resection (APR) for locally advanced rectal cancer (LARC) in patien...
Detailed Description
Locally advanced rectal cancers (LARC) threaten the normal surgical margins and therefore needs neoadjuvant (chemo-) radiotherapy to down-stage the tumor before surgery. The Norwegian Radium Hospital ...
Eligibility Criteria
Inclusion
- Patients with primary rectal adenocarcinoma that have received radiation ≥25 Gy to the pelvis.
- operation with APR with laparoscopic robot assisted technique.
- have accepted and signed the consent form.
Exclusion
- APR for other reasons
Key Trial Info
Start Date :
October 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 5 2022
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04324567
Start Date
October 9 2019
End Date
March 5 2022
Last Update
April 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Norwegian Radium Hospital Oslo University Hospital
Oslo, Norway, 0379